Effect of Electromyostimulation on Bone

U

University of Erlangen-Nürnberg Medical School

Status and phase

Completed
Phase 3

Conditions

Osteopenia
Falls
Sarcopenia

Treatments

Device: whole-body electromyostimulation
Other: wellness control group.

Study type

Interventional

Funder types

Other

Identifiers

NCT01296776
EMS-Bone-2011
EMS_Bone_2011/2012 (Other Grant/Funding Number)
EK_NO. 4184/2010

Details and patient eligibility

About

Although there is some evidence that whole body electromyostimulation(WB-EMS) affect bone via its acute and longitudinal effects on muscle mass and strength, the corresponding impact on bone density and falls in older adults has not been assessed yet. The investigators hypothesize that WB-EMS significantly affects bone parameters as assessed by DXA, and significantly reduce fall rate and ratio in a cohort of frail elderly women.

Enrollment

78 patients

Sex

Female

Ages

70 to 99 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • female gender
  • 70 years and older
  • osteopenia according to WHO
  • BMI < 24 kg/m2
  • living independently in the area of Erlangen-Nurnberg

Exclusion criteria

  • medication or diseases affecting bone metabolism (including HRT)
  • > 1 hour/week of exercise
  • epilepsy, grave neurologic disturbances,
  • cardiac pacemaker, grave circulatory disorders,
  • abdomen/groin hernia,
  • tuberculosis,
  • cancer,
  • inflammable diseases,
  • bleeding tendencies,

Trial design

78 participants in 2 patient groups, including a placebo group

whole-body electromyostimulation
Active Comparator group
Description:
20 min of whole-body electromyostimulation with sequences of 6 sec of current and 4 sec at 85 Hz performed during low-intensity/low amplitude movements. 3 sessions / 14 days for 12 months
Treatment:
Device: whole-body electromyostimulation
wellness control group
Placebo Comparator group
Description:
Low intensity, low frequency exercise that focus on well being. 1 session/week for 10 weeks. 10 blocks of exercise with intermittent periods of 100 weeks of rest
Treatment:
Other: wellness control group.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems